Kayla Lillian Mccrory, PA-C | |
100 Norman Rd, Corinth, MS 38834-9372 | |
(662) 205-4762 | |
Not Available |
Full Name | Kayla Lillian Mccrory |
---|---|
Gender | Female |
Speciality | Physician Assistant - Medical |
Location | 100 Norman Rd, Corinth, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063276277 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363AM0700X | Physician Assistant - Medical | PA00773 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kayla Lillian Mccrory, PA-C 100 Norman Rd, Corinth, MS 38834-9372 Ph: (662) 205-4762 | Kayla Lillian Mccrory, PA-C 100 Norman Rd, Corinth, MS 38834-9372 Ph: (662) 205-4762 |
News Archive
Cell Therapeutics, Inc. announced today that it has been added to the Russell 3000, Russell 2000 and Russell Global Indexes posted by Russell Investments on June 27, 2011.
The U.S. journal Science on Thursday published the results of a controversial study in which researchers at the Erasmus Medical Center in the Netherlands "identified five mutations apparently necessary to make the [H5N1] bird flu virus spread easily among ferrets, which catch the same flus that humans do," the New York Times reports (McNeil, 6/21).
Scientists may have discovered a new therapeutic approach to treat ER+ breast cancer using androgen receptor-stimulating drugs.
Rand Paul, a Kentucky GOP Senate candidate, sees Medicare and Medicaid patients, even as he opposes federal "handouts" and is facing criticism from his Democratic opponent for not releasing his Medicare billing records, The Associated Press reported.
Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule treatments for cancer, today announced that it has entered into a license agreement with the Spanish National Cancer Research Centre (CNIO) for the exclusive, worldwide rights to develop and commercialise several novel kinase inhibitors for the treatment of cancer.
› Verified 7 days ago